- Home
- APLT vs SSP Comparison
APLT vs SSP Comparison
Compare APLT & SSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- SSP
- Stock Information
- Founded
- APLT 2016
- SSP 1878
- Country
- APLT United States
- SSP United States
- Employees
- APLT N/A
- SSP N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- SSP Broadcasting
- Sector
- APLT Health Care
- SSP Industrials
- Exchange
- APLT Nasdaq
- SSP Nasdaq
- Market Cap
- APLT 178.6M
- SSP 205.8M
- IPO Year
- APLT 2019
- SSP 1988
- Fundamental
- Price
- APLT $1.30
- SSP $2.47
- Analyst Decision
- APLT Buy
- SSP Buy
- Analyst Count
- APLT 5
- SSP 2
- Target Price
- APLT $4.13
- SSP $5.50
- AVG Volume (30 Days)
- APLT 5.5M
- SSP 530.4K
- Earning Date
- APLT 11-10-2025
- SSP 11-06-2025
- Dividend Yield
- APLT N/A
- SSP N/A
- EPS Growth
- APLT N/A
- SSP N/A
- EPS
- APLT N/A
- SSP 0.48
- Revenue
- APLT $121,000.00
- SSP $2,439,152,000.00
- Revenue This Year
- APLT N/A
- SSP N/A
- Revenue Next Year
- APLT $5,935.35
- SSP $9.92
- P/E Ratio
- APLT N/A
- SSP $5.16
- Revenue Growth
- APLT N/A
- SSP 5.25
- 52 Week Low
- APLT $0.30
- SSP $1.36
- 52 Week High
- APLT $10.62
- SSP $4.17
- Technical
- Relative Strength Index (RSI)
- APLT 62.38
- SSP 50.88
- Support Level
- APLT $1.16
- SSP $2.33
- Resistance Level
- APLT $1.50
- SSP $2.41
- Average True Range (ATR)
- APLT 0.15
- SSP 0.10
- MACD
- APLT -0.01
- SSP 0.04
- Stochastic Oscillator
- APLT 66.64
- SSP 83.75
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.